Abstract
Cutaneous carcinomas are frequent neoplasms arising from epidermal cells and are classically divided into basal cell carcinoma (BCC), squamous cell carcinoma (SCC) and skin adnexal carcinoma. Basal cell carcinoma and squamous cell carcinoma are currently reported with an increasing incidence (approximatively 85/100,000 per year for BCC and 25/100,000 per year for SCC in Europe). In contrast to these frequent tumours, skin adnexal carcinomas are very rare tumours even though their overall incidence is unknown. Many different histological subtypes have been reported but usually in short series or individual clinical reports. Although a classification based on the type of cell primitively involved in proliferation is largely accepted, the current terminology is often heterogenous, increasing the confusion regarding description and proposed management. This paper will briefly review clinical and histological characteristics of the main skin adnexal tumours and principles of treatment according to updated information from the literature.
Access this chapter
Tax calculation will be finalised at checkout
Purchases are for personal use only
Preview
Unable to display preview. Download preview PDF.
Similar content being viewed by others
References
Alsaad KO, Obaidat NA, Ghazarian D (2006) Skin adnexal neoplasms — part 1: an approach to tumours of the pilosebaceous unit. J Clin Pathol, 60:129–44
Bogner PN, Fullen DR, Lowe L et al. (2003) Lymphatic mapping and sentinel lymph node biopsy in the detection of early metastasis from sweat gland carcinoma. Cancer 97: 2285–9
Cham PMH, Niehans GA, Foman N, Suwaytee P (2008) Primary cutaneous apocrine carcinoma presenting as carcinoma erysipeloides. Br J Dermatol, 158: 194–5
Cribier B, Worret WI, Braun-Falco M et al. (2006) Expression of hair and epithelial keratins and transcription factors HOXC13, LEF1, and beta-catenin in a malignant pilomatricoma: a histological and immunohistochemical study. J Cutan Pathol 33: 1–9
Dasgupta T, Wilson LD, Yu JB (2008) A retrospective review of 1,349 cases of sebaceous carcinoma. Cancer; Nov 5. Epub ahead of print
Dowd MB, Kumar RJ, Sharma R, Murali R. (2008) Diagnosis and management of sebaceous carcinoma: an australian experience. ANZ J Surg 78: 158–63
Friedman PM, Friedman RH, Jiang SB et al. (1999) Microcystic adnexal carcinoma: collaborative series review and update. J Am Acad Dermatol 41: 225–31
Gabillot-Carré M, Weill F, Mamelle G et al. (2006) Microcystic adnexal carcinoma: report of seven cases including one with lung metastasis. Dermatology, 212: 221–8
Gutermuth J, Audring H, Voit C et al. (2004) Antitumour activity of paclitaxel and interferon-alpha in a case of metastatic eccrine porocarcinoma. J Eur Acad Dermatol Venereol 18: 477–9
Harari PM, Shimm DS, Bangert JL, Cassady JR (1999). The role of radiotherapy in the treatment of malignant sweat gland neoplasms. Cancer 65: 1737–40
Huet P, Dandurand M, Pignodel C, Guillot B (1996). Metastazing eccrine porocarcinoma: report of a case and review of the literature. J Am Acad Dermatol 35: 860–4
Jo JH, Ko HC, Jang HS et al. (2005) Infiltrative trichilemmal carcinoma treated with 5% imiquimod cream. Dermatol Surg 31: 973–6
Jouary T, Kaiafa A, Lipinski P et al. (2006) Metastatic hidradenocarcinoma: efficacy of capecitabine. Arch Dermatol 142: 1366–7
Lazar AJF, Lyle S, Calonje E (2007) Sebaceous neoplasia and Torre-Muir Syndrome. CurrDiagn Pathol 13: 301–19
Naylor E, Sarkar P, Perlis CS et al. (2008) Primary cutaneous adenoid cystic carcinoma. J Am Acad Dermatol 58: 636–41
Obaidat NA, Alsaad KO, Ghazarian D (2007) Skin adnexal tumours — part 2: an approach to tumours of cutaneous sweat glands. J Clin Pathol 60:145–59
Plunkett TA, Hanby AM, Miles DW, Rubens RD (2001) Metastatic eccrine porocarcinoma: response to docetaxel (Taxotere) chemotherapy. Ann Oncol 12: 411–4
Reis JP, Tellechea O, Cunha MF, Baptista AP (1993) Trichilemmal carcinoma: review of 8 cases. J Cutan Pathol 20: 44–9
Robson A, Greene J, Ansari N et al. (2002) Eccrine porocarcinoma (malignant eccrine poroma): a clinicopathologic study of 69 cases. Am J Surg Pathol 26: 272–4
Robson A, Lazar AJ, Ben Nagi J et al. (2008) Primary cutaneous apocrine carcinoma: a clinico-pathologic analysis of 24 cases. Am J Surg Pathol 32: 682–90
Rutten A, Requena L (2008) Sweat gland carcinoma of the skin. Hautarzt 59: 151–60
Sassmannshausen J, Chaffins M. (2001) Pilomatrix carcinoma: report of a case arising from a previously excised pilomatrixoma and a review of the literature. J Am Acad Dermatol 44: 358–61
Terada T, Sato Y, Furukawa K, Sugiura M (2004) Primary cutaneous carcinoma initially diagnosed as a metastatic adenocarcinoma. Tohoku J Exp Med 203: 345–8
Thomas CJ, Wood GC, Marks VJ (2007) Mohs micrographic surgery in the treatment of rare agressive cutaneous tumors: the Geisinger experience. Dermatol Surg 33: 333–9
Tselis N, Heyd R, Vogt HG, Zamboglou N (2006) Pilomatrix carcinoma with lymph node and pulmonary metastasis. Stralenther Onkol 182: 727–32
Wildemore JK, Lee JB, Humphreys TR (2004). Mohs micrographic surgery for malignant eccrine neoplasms. Dermatol Surg 30: 1574–9
Editor information
Editors and Affiliations
Rights and permissions
Copyright information
© 2009 Springer-Verlag France, Paris
About this chapter
Cite this chapter
Guillot, B. (2009). Unusual cutaneous malignancies: cutaneous adnexal tumours. In: Belkacémi, Y., Mirimanoff, RO., Ozsahin, M. (eds) Management of Rare Adult Tumours. Springer, Paris. https://doi.org/10.1007/978-2-287-92246-6_53
Download citation
DOI: https://doi.org/10.1007/978-2-287-92246-6_53
Publisher Name: Springer, Paris
Print ISBN: 978-2-287-92245-9
Online ISBN: 978-2-287-92246-6
eBook Packages: MedicineMedicine (R0)